Simulations Plus, Inc. (SLP)
NCM · Common · CUSIP 713831105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SLP and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
713831105 (prev. 829214105 )
Market Cap
Large Cap
Previous Symbol
SIMU (changed 3/17/2004)
Business: Simulations Plus, Inc. is the leading developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) neural net and simulation software for the pharmaceutical and biotechnology industries today. The Company’s software allows pharmaceutical scientists to predict certain key potential drug dynamics, such as absorption, in silico, thereby eliminating multi-million dollar clinical trial failures and speeding up the time to market of effective new medications.

Company Contact

CEO
Shawn O’Connor
CFO
Will Frederick
Headquarters
42505 10th Street West, Lancaster, CA 93534
Phone
661-723-7723 · Toll-Free 888-266-9294
Fax
661-723-5524
Investor Relations
Ms. Renee Bouche · 661-723-7723 · renee@simulations-plus.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »